Dataset Information


Genetic susceptibility to neuroblastoma.

ABSTRACT: Until recently, the genetic basis of neuroblastoma, a heterogeneous neoplasm arising from the developing sympathetic nervous system, remained undefined. The discovery of gain-of-function mutations in the ALK receptor tyrosine kinase gene as the major cause of familial neuroblastoma led to the discovery of identical somatic mutations and rapid advancement of ALK as a tractable therapeutic target. Inactivating mutations in a master regulator of neural crest development, PHOX2B, have also been identified in a subset of familial neuroblastomas. Other high penetrance susceptibility alleles likely exist, but together these heritable mutations account for less than 10% of neuroblastoma cases. A genome-wide association study of a large neuroblastoma cohort identified common and rare polymorphisms highly associated with the disease. Ongoing resequencing efforts aim to further define the genetic landscape of neuroblastoma.


PROVIDER: S-EPMC5604862 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2008-01-01 | S-EPMC2672043 | BioStudies
2018-01-01 | S-EPMC6893873 | BioStudies
2012-01-01 | S-EPMC3730824 | BioStudies
1000-01-01 | S-EPMC3683972 | BioStudies
2020-01-01 | S-EPMC7158874 | BioStudies
2008-01-01 | S-EPMC2587486 | BioStudies
2013-01-01 | S-EPMC3808344 | BioStudies
1000-01-01 | S-EPMC3095533 | BioStudies
2019-01-01 | S-EPMC6855946 | BioStudies
2014-01-01 | S-EPMC4269829 | BioStudies